Elevation Oncology (ELEV) Short Interest Ratio & Short Volume $0.38 0.00 (-0.84%) Closing price 04:00 PM EasternExtended Trading$0.38 0.00 (-0.13%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Elevation Oncology Short Interest DataElevation Oncology (ELEV) has a short interest of 2.55 million shares, representing 4.81% of the float (the number of shares available for trading by the public). This marks a -42.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 1.50 million shares to cover all short positions.Current Short Interest2,550,000 sharesPrevious Short Interest4,430,000 sharesChange Vs. Previous Month-42.44%Dollar Volume Sold Short$778.26 thousandShort Interest Ratio1.5 Days to CoverLast Record DateMay 31, 2025Outstanding Shares59,224,000 sharesFloat Size53,000,000 sharesShort Percent of Float4.81%Today's Trading Volume997,616 sharesAverage Trading Volume1,499,302 sharesToday's Volume Vs. Average67% Short Selling Elevation Oncology? Sign up to receive the latest short interest report for Elevation Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELEV Short Interest Over TimeELEV Days to Cover Over TimeELEV Percentage of Float Shorted Over Time Elevation Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20252,550,000 shares $778.26 thousand -42.4%4.8%1.5 $0.31 5/15/20254,430,000 shares $1.33 million +22.4%8.4%3.2 $0.30 4/30/20253,620,000 shares $1.35 million -58.1%7.0%2.6 $0.37 4/15/20258,630,000 shares $2.71 million +5.8%16.6%5.5 $0.31 3/31/20258,160,000 shares $2.11 million -6.7%15.7%3.3 $0.26 3/15/20258,750,000 shares $4.66 million +2.2%16.8%3.5 $0.53 2/28/20258,560,000 shares $4.48 million -2.6%16.4%4 $0.52 2/15/20258,790,000 shares $5.90 million +0.2%16.9%4.2 $0.67 1/31/20258,770,000 shares $6.08 million -1.9%16.9%4.3 $0.69 1/15/20258,940,000 shares $6.51 million +38.8%17.2%4.6 $0.73 Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 12/31/20246,440,000 shares $3.62 million +4.7%12.4%6.3 $0.56 12/15/20246,150,000 shares $3.91 million +0.3%11.8%7.9 $0.64 11/30/20246,130,000 shares $3.90 million +1.8%11.8%8.5 $0.64 11/15/20246,020,000 shares $3.20 million -3.1%11.6%8.6 $0.53 10/31/20246,210,000 shares $3.57 million +4.4%12.4%8.1 $0.57 10/15/20245,950,000 shares $3.09 million -3.3%11.9%5.1 $0.52 9/30/20246,150,000 shares $3.69 million -1.8%12.3%5.2 $0.60 9/15/20246,260,000 shares $3.81 million -4.7%12.5%4.7 $0.61 8/31/20246,570,000 shares $5.11 million +2.7%13.1%5.1 $0.78 8/15/20246,400,000 shares $4.62 million -4.2%12.8%5 $0.72 7/31/20246,680,000 shares $17.57 million No Change13.8%5.8 $2.63 7/15/20246,680,000 shares $20.17 million +28.7%14.9%8.1 $3.02 6/30/20245,190,000 shares $14.01 million -2.1%10.8%6.9 $2.70 6/15/20245,300,000 shares $17.12 million -0.2%11.1%7.7 $3.23 5/31/20245,310,000 shares $21.35 million +3.9%11.3%7.7 $4.02 5/15/20245,110,000 shares $19.06 million +4.5%10.9%5.5 $3.73 4/30/20244,890,000 shares $17.36 million -1.2%11.5%4.9 $3.55 4/15/20244,950,000 shares $21.93 million -1.2%13.0%4.2 $4.43 3/31/20245,010,000 shares $25.70 million +8.2%12.6%1.6 $5.13 3/15/20244,630,000 shares $20.33 million +28.3%11.6%1.6 $4.39 2/29/20243,610,000 shares $15.92 million -10.0%9.1%1.3 $4.41 2/15/20244,010,000 shares $11.11 million +13.9%11.6%1.5 $2.77 1/31/20243,520,000 shares $9.79 million +95.6%10.1%1.4 $2.78 1/15/20241,800,000 shares $4.93 million +124.0%5.2%0.8 $2.74 12/31/2023803,700 shares $431.59 thousand +21.0%2.5%0.5 $0.54 12/15/2023664,500 shares $338.96 thousand +12.0%2.1%2.8 $0.51 11/30/2023593,500 shares $315.74 thousand -10.8%1.8%2.7 $0.53 11/15/2023665,100 shares $307.28 thousand -22.3%2.1%2.9 $0.46 10/31/2023856,100 shares $410.93 thousand -8.2%2.8%4.1 $0.48 10/15/2023932,200 shares $616.18 thousand +0.6%3.1%5.6 $0.66Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 9/30/2023926,500 shares $613.90 thousand -24.7%3.1%4.9 $0.66 9/15/20231,230,000 shares $895.44 thousand +1.7%4.1%5.5 $0.73 8/31/20231,210,000 shares $924.44 thousand -4.7%5.2%2.6 $0.76 8/15/20231,270,000 shares $1.16 million +0.8%5.4%0.8 $0.91 7/31/20231,260,000 shares $1.51 million -4.6%4.7%0.7 $1.20 7/15/20231,320,000 shares $1.97 million -11.4%8.6%0.7 $1.49 6/30/20231,490,000 shares $2.26 million -4.5%9.8%0.8 $1.52 6/15/20231,560,000 shares $2.31 million -39.3%10.2%0.8 $1.48 5/31/20232,570,000 shares $10.85 million +596.3%16.4%1.2 $4.22 5/15/2023369,100 shares $1.35 million -64.2%2.3%0.4 $3.67 4/30/20231,030,000 shares $2.71 million +688.7%6.7%1.3 $2.63 4/15/2023130,600 shares $254.67 thousand +6.0%0.9%0.3 $1.95 3/31/2023123,200 shares $234.08 thousand +135.6%0.8%0.2 $1.90 3/15/202352,300 shares $121.34 thousand +28.2%0.3%0.1 $2.32 2/28/202340,800 shares $44.98 thousand +22.5%0.3%0.4 $1.10 2/15/202333,300 shares $32.63 thousand -18.2%0.2%0.4 $0.98 1/31/202340,700 shares $40.70 thousand +20.8%0.3%0.5 $1.00 1/15/202333,700 shares $33.40 thousand -29.4%0.2%0.4 $0.99 12/30/202247,700 shares $45.32 thousand +10.7%0.3%0.7 $0.95 12/15/202243,100 shares $40.95 thousand -2.1%0.3%1.1 $0.95 11/30/202244,000 shares $39.78 thousand -10.4%0.3%1 $0.90 11/15/202249,100 shares $47.63 thousand +6.1%0.3%1 $0.97 10/31/202246,300 shares $50.00 thousand +42.5%0.3%0.9 $1.08 10/15/202232,500 shares $35.43 thousand -62.7%0.2%0.5 $1.09 9/30/202287,200 shares $98.54 thousand +76.5%0.6%1.1 $1.13 9/15/202249,400 shares $61.75 thousand -12.6%0.3%0.5 $1.25 8/31/202256,500 shares $64.98 thousand +61.4%0.4%0.4 $1.15 8/15/202235,000 shares $47.60 thousand -38.1%0.2%0.1 $1.36 7/31/202256,500 shares $71.19 thousand -13.5%0.4%0.1 $1.26 7/15/202265,300 shares $89.46 thousand -92.8%0.5%0.1 $1.37 6/30/2022905,700 shares $1.27 million -1.1%6.5%1.5 $1.40 6/15/2022915,900 shares $1.24 million -18.2%6.6%1.5 $1.35 5/31/20221,120,000 shares $2.53 million +19.5%8.1%2 $2.26 5/15/2022937,000 shares $3.35 million +0.2%9.2%21.6 $3.57 4/30/2022935,600 shares $2.87 million +21.5%9.2%18.4 $3.07 4/15/2022770,300 shares $1.92 million +8.9%7.6%15.3 $2.49 3/31/2022707,300 shares $1.78 million +27.9%N/A14.1 $2.52 3/15/2022552,900 shares $1.39 million +4.5%5.4%9 $2.51 2/28/2022529,100 shares $1.79 million -0.2%5.2%6.9 $3.38 2/15/2022530,200 shares $2.15 million +619.4%5.2%7.1 $4.05 1/31/202273,700 shares $322.07 thousand +12.5%0.6%1 $4.37 1/15/202265,500 shares $393 thousand +2.8%N/A1.2 $6.00 12/31/202163,700 shares $383.47 thousand -55.2%0.5%1.2 $6.02 12/15/2021142,200 shares $675.45 thousand +20.1%1.0%3 $4.75 11/30/2021118,400 shares $776.31 thousand +0.9%0.9%2.5 $6.56 11/15/2021117,400 shares $896.94 thousand -7.3%0.8%3.2 $7.64 10/29/2021126,600 shares $1.05 million -8.4%0.9%3.2 $8.27 10/15/2021138,200 shares $1.10 million -0.4%1.0%3.1 $7.96 9/30/2021138,700 shares $1.08 million +4,234.4%1.0%2.7 $7.79 9/15/20213,200 shares $31.68 thousand -79.6%0.0%0 $9.90Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 8/31/202115,700 shares $183.69 thousand -17.8%0.1%0.1 $11.70 8/13/202119,100 shares $219.65 thousand No Change0.2%0.2 $11.50 ELEV Short Interest - Frequently Asked Questions What is Elevation Oncology's current short interest? Short interest is the volume of Elevation Oncology shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 2,550,000 shares of ELEV short. 4.81% of Elevation Oncology's shares are currently sold short. Learn More on Elevation Oncology's current short interest. What is a good short interest ratio for Elevation Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELEV shares currently have a short interest ratio of 2.0. Learn More on Elevation Oncology's short interest ratio. Which institutional investors are shorting Elevation Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Elevation Oncology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Elevation Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.81% of Elevation Oncology's floating shares are currently sold short. Is Elevation Oncology's short interest increasing or decreasing? Elevation Oncology saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 2,550,000 shares, a decrease of 42.4% from the previous total of 4,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Elevation Oncology's float size? Elevation Oncology currently has issued a total of 59,224,000 shares. Some of Elevation Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elevation Oncology currently has a public float of 53,000,000 shares. How does Elevation Oncology's short interest compare to its competitors? 4.81% of Elevation Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elevation Oncology: Immix Biopharma, Inc. (1.75%), InterCure Ltd. (0.05%), Elutia Inc. (0.27%), PyroGenesis Canada Inc. (0.10%), CervoMed Inc. (4.95%), Alto Neuroscience, Inc. (13.68%), Vistagen Therapeutics, Inc. (2.04%), Surrozen, Inc. (0.94%), Skye Bioscience, Inc. (17.41%), MediciNova, Inc. (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Elevation Oncology stock? Short selling ELEV is an investing strategy that aims to generate trading profit from Elevation Oncology as its price is falling. ELEV shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elevation Oncology? A short squeeze for Elevation Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELEV, which in turn drives the price of the stock up even further. How often is Elevation Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELEV, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies IMMX Short Interest Data INCR Short Interest Data ELUT Short Interest Data PYRGF Short Interest Data CRVO Short Interest Data ANRO Short Interest Data VTGN Short Interest Data SRZN Short Interest Data SKYE Short Interest Data MNOV Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELEV) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
